Spago Nanomedical AB

OSTO:SPAGO (Sweden)  
kr 0.19 (+1.09%) Nov 27
At Loss
P/B:
1.58
Market Cap:
kr 64.76M ($ 5.93M)
Enterprise V:
kr 24.82M ($ 2.27M)
Volume:
36.92K
Avg Vol (2M):
83.71K
Warning! GuruFocus detected 2 Severe warning signs with SPAGO. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
36.92K
Market Cap kr:
64.76M
Market Cap $:
5.93M
At Loss
Avg Vol (2M):
83.71K
Enterprise Value kr:
24.82M
Enterprise Value $:
2.27M
PB Ratio:
1.58
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocks™

Business Description

Spago Nanomedical AB

ISIN : SE0004899474
https://www.spagonanomedical.se
Scheelevagen 22, Lund, SWE, SE-223 63
Compare
Compare
XSAT:PHALOSTO:PILAOSTO:CYXOOSTO:ASAPXSAT:ALTEOSTO:DIABIOOSTO:REDWOSTO:PHARMOSTO:FLUIOSTO:MODTXOCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAHKSE:02269XBRU:ARGXBNTX
Traded in other countries / regions
SPAGO.Sweden7UX.Germany
IPO Date
2012-12-27
Description
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Financial Strength

10/10
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.87
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.56
Distress
Grey
Safe
Beneish M-Score 0.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -2.9
3-Year EBITDA Growth Rate 14
3-Year EPS without NRI Growth Rate 13.3
3-Year FCF Growth Rate 20.3
3-Year Book Growth Rate -64.1
Future 3-5Y Total Revenue Growth Rate 255.82

Momentum Rank

1/10
Name Current Vs Industry Vs History
5-Day RSI 38.01
9-Day RSI 39.89
14-Day RSI 40.78
6-1 Month Momentum % -14.17
12-1 Month Momentum % -16.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.26
Quick Ratio 8.26
Cash Ratio 7.16
Days Sales Outstanding 46.44
Days Payable 87.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -77.6

Profitability Rank

1/10
Name Current Vs Industry Vs History
Gross Margin % -755.61
Operating Margin % -1709.78
Net Margin % -1683.7
FCF Margin % -1795.8
ROE % -50.99
ROA % -45.79
ROIC % -103.28
ROC (Joel Greenblatt) % -4350.72
ROCE % -51.58

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 23.25
PB Ratio 1.58
Price-to-Tangible-Book 1.55
EV-to-EBIT -0.72
EV-to-Forward-EBIT -0.85
EV-to-EBITDA -0.72
EV-to-Forward-EBITDA -0.85
EV-to-Revenue 12.25
EV-to-Forward-Revenue 3.27
EV-to-FCF -0.79
Price-to-Net-Current-Asset-Value 1.55
Price-to-Net-Cash 1.86
Earnings Yield (Greenblatt) % -139.08
FCF Yield % -56.15

Financials (Next Earnings Date:2025-02-07 Est.)

OSTO:SPAGO's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Spago Nanomedical AB Executives

Details

GF Value: kr0.34

OSTO:SPAGO

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 2.025
EPS (TTM) (kr) -0.16
Beta 0.15
Volatility % 62.95
14-Day RSI 40.78
14-Day ATR (kr) 0.026317
20-Day SMA (kr) 0.1987
12-1 Month Momentum % -16.54
52-Week Range (kr) 0.151 - 0.59
Shares Outstanding (Mil) 348.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Spago Nanomedical AB Filings

Filing Date Document Date Form
No Filing Data

Spago Nanomedical AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Spago Nanomedical AB Frequently Asked Questions

What is Spago Nanomedical AB(OSTO:SPAGO)'s stock price today?
The current price of OSTO:SPAGO is kr0.19. The 52 week high of OSTO:SPAGO is kr0.59 and 52 week low is kr0.15.
When is next earnings date of Spago Nanomedical AB(OSTO:SPAGO)?
The next earnings date of Spago Nanomedical AB(OSTO:SPAGO) is 2025-02-07 Est..
Does Spago Nanomedical AB(OSTO:SPAGO) pay dividends? If so, how much?
Spago Nanomedical AB(OSTO:SPAGO) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.